Association of SYK genetic variations with breast cancer pathogenesis

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 5, 2013, Pages 3309-3314

  Shakeel, Shafaq ^a   Mahjabeen, Ishrat ^a   Kayani, Mahmood Akhtar ^a   Faryal, Rani ^a,b  

^a COMSATS Institute of Information Technology ^*  (Pakistan)

^b QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

Breast cancer; SSCP; SYK; Tumor suppressor gene

Indexed keywords

PROTEIN KINASE SYK; PROTEIN TYROSINE KINASE; SIGNAL PEPTIDE;

ADULT; ARTICLE; BREAST TUMOR; CASE CONTROL STUDY; CHILD; FEMALE; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; HUMAN; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROGNOSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; PROTEIN-TYROSINE KINASES;

EID: 84880364382     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.5.3309     Document Type: Article

References (24)

1. Abbasi S, Azimi C, Othman F (2009). Risk factors for breast cancer in Iranian women: a case control study. Inter J Cancer Res, 5, 1-11.
2. Ahmad M (2003). Risk factors for breast cancer among women attending breast clinic in University Malaya Medical Centre Kuala Lumpur. NCD Malaysia, 2, 23-31.
3. Clamp A, Danson S, Clemons M (2003). Hormonal and genetic risk factors for breast cancer. The Surgeon, 1, 23-31.
4. Coopman CP, Mueller SC (2006). Mini review: the SYK tyrosine kinase: a new negative regulator in tumor growth and progression. Cancer Lett, 241, 159-73.
5. Coopman PJP, Do MTH, Barth M, et al (2000). The SYK tyrosine kinase suppresses malignant growth of human breast cancer cells. Nature, 406, 742-7.
6. Harrison AP, Srinivasan K, Binu, VS, et al (2010). Risk factors for breast cancer among women attending a tertiary care hospital in southern India. Inter J Collaborative Res on Internal Medicine & Public Health, 2, 109-16.
7. Hu YH, Nagata C, Shimizu H, et al (1997). Association of body mass index, physical activity, and reproductive histories with breast cancer: a case-control study in Gifu, Japan. Breast Cancer Res Treat, 43, 65-72.
8. Hunter S, Sato N, Kim MK, et al (2000). Structural requirements of SYK kinase for Fcgamma receptor-mediated phagocytosis. Exp Hematol, 27, 875-84.
9. Inayat U, Kayani MA, Rani F (2012). Sporadic mutation and expressional analysis of spleen tyrosine kinase gene in breast cancer. Pol J Pathol, 2, 106-11.
10. Jemal A, Bray F, Melissa M (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
11. Kanwal S, Kayani MA, Faryal R (2012). Identification of novel SNPs in SYK gene of breast cancer patients: computational analysis of SNPs in the 50UTR. Mol Biol Rep, 39, 8345-51.
12. Kruk J (2007). Association of lifestyle and other risk factors with breast cancer according to menopausal status: a case-control study in the region of Western Pomerania (Poland). Asian Pac J Cancer Prev, 8, 513-24.
13. Lakhani SR, Collins N, Sloane JP, et al (1995). Loss of heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol Mol Pathol, 48, 74-8.
14. Latour S, Zhang J, Siraganian RP, et al (1998). A unique insert in the linker domain of SYK is necessary for its function in immunoreceptor signalling. EMBO J, 17, 2584-95.
15. Liu BA, Jablonowski K, Raina M, et al (2006). The human and mouse complement of SH2 domain proteins-establishing the boundaries of phosphotyrosine signaling. Mol Cell, 22, 851-68.
16. Mahjabeen I, Baig RM, Masood N, et al (2012). Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol Oncol Res, 10, 9567.
17. Mc Pherson K, Stell CM, Dixon JM (2000). Breast cancerepidemiology, risk factors, and genetics. Br Med J, 321, 624-8.
18. Minami Y, Ohuchi N, Fukao A (1997). Risk factors for breast cancer: a case-control study of screen-detected breast cancer Miyagi Prefecture, Japan. Breast Cancer Res Treat, 44, 225-33.
19. Naeem N, Nasir A, Aman Z, et al (2008). Frequency of HER- 2/NEU receptor positivity and its association with other features of breast cancer. J Ayub Med Coll Abbottabad, 20, 23-6.
20. Osborne C, Wilson P, Tripathy D (2004). Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. Oncologist, 9, 361-77.
21. de Castro RO (2011). Regulation and Function of SYK Tyrosine Kinase in Mast Cell Signaling and Beyond. J Signal Transduction, 10, 507291.
22. Toyama T, Iwase H, Yamashita H, et al (2002). Reduced expression of the SYK gene is correlated with poor prognosis in human breast cancer. Cancer, 189, 97-102.
23. Wang L, Duke L, Zhang PS, et al (2003). Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer. Cancer Res, 63, 4724-30.
24. Yuan Y, Mendez R, Sahin A, et al (2001). Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res, 61, 5558-61.